Cargando…
Relationship Study of The Verified Human Epidermal Growth Factor Receptor 2 Amplification with Other Tumor Markers and Clinicohistopathological Characteristics in Patients with Invasive Breast Cancer, Using Chromogenic In Situ Hybridization
OBJECTIVE: Human epidermal growth factor receptor 2 (HER-2), as a crucial factor involved in about 20% of breast cancer cases, is one of the most reliable tumor markers to determine prognosis and therapeutic trend of this disease. This marker is generally assessed by immunohistochemistry (IHC) techn...
Autores principales: | Sarli, Abdolazim, Mozdarani, Hossein, Rakhshani, Nasser, Mozdarani, Sohail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582419/ https://www.ncbi.nlm.nih.gov/pubmed/31210439 http://dx.doi.org/10.22074/cellj.2019.6219 |
Ejemplares similares
-
High frequency of microdeletion in TTY2 gene family in peripheral blood leukocytes of non-obstructive azoospermia patients
por: Zonozi, Farideh, et al.
Publicado: (2017) -
Biological Complexities in Radiation Carcinogenesis and Cancer Radiotherapy: Impact of New Biological Paradigms
por: Mozdarani, Hossein
Publicado: (2012) -
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
por: Elbauomy Elsheikh, Somaia, et al.
Publicado: (2007) -
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
por: Reis-Filho, Jorge S, et al.
Publicado: (2005) -
Chromogenic in situ hybridization
compared with other approaches to evaluate HER2/neu status in breast
carcinomas
por: Rosa, F.E., et al.
Publicado: (2013)